ZA919185B - Controlled release compositions - Google Patents

Controlled release compositions

Info

Publication number
ZA919185B
ZA919185B ZA919185A ZA919185A ZA919185B ZA 919185 B ZA919185 B ZA 919185B ZA 919185 A ZA919185 A ZA 919185A ZA 919185 A ZA919185 A ZA 919185A ZA 919185 B ZA919185 B ZA 919185B
Authority
ZA
South Africa
Prior art keywords
controlled release
release compositions
core
vinylpyrrolidine
kaolin
Prior art date
Application number
ZA919185A
Other languages
English (en)
Inventor
John Michael Newton
Michael Newton John
Original Assignee
British Tech Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Tech Group filed Critical British Tech Group
Publication of ZA919185B publication Critical patent/ZA919185B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/2853Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Lubricants (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Air Bags (AREA)
  • Valve Device For Special Equipments (AREA)
  • Control Of Throttle Valves Provided In The Intake System Or In The Exhaust System (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Glass Compositions (AREA)
ZA919185A 1990-11-22 1991-11-20 Controlled release compositions ZA919185B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909025372A GB9025372D0 (en) 1990-11-22 1990-11-22 Pharmaceutical dosage forms

Publications (1)

Publication Number Publication Date
ZA919185B true ZA919185B (en) 1992-09-30

Family

ID=10685781

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA919185A ZA919185B (en) 1990-11-22 1991-11-20 Controlled release compositions

Country Status (14)

Country Link
EP (1) EP0559813B1 (de)
JP (1) JPH06502636A (de)
KR (1) KR930701984A (de)
AT (1) ATE151283T1 (de)
AU (1) AU653372B2 (de)
CA (1) CA2096733A1 (de)
DE (1) DE69125619T2 (de)
ES (1) ES2101082T3 (de)
FI (1) FI932320A (de)
GB (2) GB9025372D0 (de)
HU (1) HUT65756A (de)
NO (1) NO931859L (de)
WO (1) WO1992009270A1 (de)
ZA (1) ZA919185B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
GB2257363B (en) * 1991-01-30 1994-09-28 Wellcome Found Water dispersible tablets containing acyclovir
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
TW246635B (de) * 1992-10-08 1995-05-01 Shell Internat Res Schappej B V
DK66493D0 (da) * 1993-06-08 1993-06-08 Ferring A S Praeparater, isaer til brug ved behandling af inflammatoriske tarmsygdomme eller til at opnaa forbedret saarheling
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US6028190A (en) 1994-02-01 2000-02-22 The Regents Of The University Of California Probes labeled with energy transfer coupled dyes
US6166024A (en) 1995-03-30 2000-12-26 Mayo Foundation For Medical Education And Research Use of topical azathioprine and thioguanine to treat colorectal adenomas
TW474824B (en) * 1996-09-13 2002-02-01 Basf Ag The production of solid pharmaceutical forms
DE19649100A1 (de) * 1996-11-27 1998-06-04 Lohmann Therapie Syst Lts Verfahren zur verlustarmen Herstellung wirkstoffhaltiger scheibenförmiger Formkörper und diese enthaltende transdermale therapeutische Systeme
CA2327685C (en) 1998-04-03 2008-11-18 Bm Research A/S Controlled release composition
DE19840256A1 (de) * 1998-09-03 2000-03-09 Basf Ag Verfahren zur Herstellung von beschichteten festen Dosierungsformen
JP2002535353A (ja) 1999-01-29 2002-10-22 ロザン ファルマ ゲゼルシャフトミットベシュレンクテルハフツンク 医薬品組成物
WO2002005788A1 (en) * 2000-07-14 2002-01-24 Universiteit Gent Composite solid shaped articles for the controlled delivery of biologically active ingredients
EP1429739A1 (de) 2001-09-21 2004-06-23 Egalet A/S Polymer-freigabe-system
US20040253310A1 (en) 2001-09-21 2004-12-16 Gina Fischer Morphine polymer release system
US20030203027A1 (en) * 2002-04-26 2003-10-30 Ethicon, Inc. Coating technique for deposition of drug substance on a substrate
CA2484632C (en) * 2002-05-07 2012-12-11 Control Delivery Systems, Inc. Processes for forming a drug delivery device
GB0214013D0 (en) 2002-06-18 2002-07-31 Euro Celtique Sa Pharmaceutical product
WO2004041252A1 (en) 2002-11-08 2004-05-21 Egalet A/S Controlled release carvedilol compositions
ATE399538T1 (de) 2003-03-26 2008-07-15 Egalet As Matrixzubereitungen für die kontrollierte darreichung von arzneistoffen
EP1610767B1 (de) 2003-03-26 2011-01-19 Egalet A/S Morphin-system mit kontrollierter freisetzung
DE102004042139B4 (de) * 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
US8821928B2 (en) 2007-06-04 2014-09-02 Egalet Ltd. Controlled release pharmaceutical compositions for prolonged effect
WO2010089132A1 (en) 2009-02-06 2010-08-12 Egalet A/S Immediate release composition resistant to abuse by intake of alcohol
EP2445487A2 (de) 2009-06-24 2012-05-02 Egalet Ltd. Retard-formulierungen
EP2542243A2 (de) * 2010-03-04 2013-01-09 Wockhardt Limited Darreichungsform mit modifizierter freisetzung
JP2015521988A (ja) 2012-07-06 2015-08-03 イガレット・リミテッド 制御放出用乱用防止性医薬組成物
CN110022794A (zh) * 2016-10-05 2019-07-16 泰坦医药品公司 具有减少的突释的用于药物递送的可植入装置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
GB2170104A (en) * 1985-01-30 1986-07-30 Warner Lambert Co Coated pharmaceutical dosage forms
IE861284L (en) * 1986-05-14 1987-11-14 Birex Res And Dev Ltd And Carm Controlled release ketoprofen.
US4810501A (en) * 1986-06-17 1989-03-07 Warner-Lambert Company Sustained release pharmaceutical preparations
GB8618811D0 (en) * 1986-08-01 1986-09-10 Approved Prescription Services Sustained release ibuprofen formulation
US5158881A (en) * 1987-11-17 1992-10-27 Brown University Research Foundation Method and system for encapsulating cells in a tubular extrudate in separate cell compartments

Also Published As

Publication number Publication date
AU653372B2 (en) 1994-09-29
DE69125619T2 (de) 1997-09-11
GB2249957B (en) 1994-11-23
HUT65756A (en) 1994-07-28
HU9301499D0 (en) 1993-09-28
EP0559813A1 (de) 1993-09-15
ES2101082T3 (es) 1997-07-01
ATE151283T1 (de) 1997-04-15
DE69125619D1 (de) 1997-05-15
GB9124776D0 (en) 1992-01-15
FI932320A0 (fi) 1993-05-21
NO931859L (no) 1993-07-21
GB9025372D0 (en) 1991-01-09
EP0559813B1 (de) 1997-04-09
AU8909691A (en) 1992-06-25
KR930701984A (ko) 1993-09-08
GB2249957A (en) 1992-05-27
NO931859D0 (no) 1993-05-21
FI932320A (fi) 1993-07-09
JPH06502636A (ja) 1994-03-24
CA2096733A1 (en) 1992-05-23
WO1992009270A1 (en) 1992-06-11

Similar Documents

Publication Publication Date Title
ZA919185B (en) Controlled release compositions
DE69023896D1 (de) Zementhilfsmittel, dessen herstellung sowie zementzusammensetzung.
AU8027291A (en) Coated solid medicament form having releasability in large intestine
CA2376226A1 (en) New formulation
AU9075591A (en) N-halochitosans, their preparation and uses
AP9100285A0 (en) Substituted benzimidazoles,process for their preparation and their pharmaceutical use
AU8259291A (en) Water dilutable copolymer, its preparation and its use and aqueous coating compositions
DE69111507D1 (de) Isolationsmaterial und dessen Herstellung.
CA2254848A1 (en) Methods for sterilizing male mammals
ATE92752T1 (de) Spruehgetrocknete ibuprofen-zusammensetzungen.
AU7110891A (en) Polymer composition imparting low surface energy
CA2042560A1 (en) Paper composition and uses therefor
AU8271191A (en) Indolonaphthyridines, their production and use
MX9202536A (es) Antibioticos tetraciclicos y procedimiento para su preparacion.
AU3708397A (en) Sulfonic ester derivatives, process for preparing the same, and use thereof
MX9205982A (es) Agente para la preparacion de fibras, degradable biologicamente.
AU8045191A (en) Inorganic solid and polymer composition
RU93041454A (ru) Композиция с управляемым выделением, способ ее получения
AU9139591A (en) Process for the preparation of bromonitro-alcohols, dibromonitro-alcohols and blends thereof
AU8014391A (en) Coating composition and polymer for use therein
EP0492567A3 (en) Burned anhydrite, procedure for its production and its use
EP0678293A3 (de) Pyridoxinester enthaltendes Präparat, Verfahren zu dessen Herstellung und dessen Verwendung.
FI973631A (fi) 1,3-diolipohjaiset eetterit, menetelmä 1,3-diolipohjaisten eetterien valmistamiseksi sekä eetterien käyttö
AU647469C (en) benzimidazole derivatives, their production and use
AU8744091A (en) Epoxycarbacyclin precursors, their preparation and their use